Provexis PLC
23 January 2006
PROVEXIS PLC
('Provexis' or the 'Company')
Significant Increase in Number of Distribution Outlets for SircoTM
Provexis, the nutraceutical company that develops scientifically-proven
functional and medical foods, announces a significant increase in the number of
distribution outlets for its SircoTM heart health juice drink, under the terms
of its most recent distribution agreement with a market leading supermarket
chain.
Further to the Company's announcement of 9 January 2006 detailing its third
distribution agreement, SircoTM will now be available in 550 of this retailer's
stores from 30 January 2006, representing an increase of 350 outlets. Sirco is
now available in 211 Sainsbury's stores and will be available in 123 Waitrose
stores from 23 January 2006. This will bring the total UK distribution base for
Sirco to 884 stores by the end of January 2006.
SircoTM is the first heart health product to contain the patented FruitflowTM
technology. FruitflowTM was developed by Provexis in order to help regular
'healthy' consumers reduce the risk of heart attack and stroke. The natural
bioactive works by reducing blood platelet aggregation ('thinning the blood'), a
significant contributing factor to a thrombosis (internal blood clot). SircoTM
carries the health claim 'Helps to Maintain a Healthy Heart and Benefits
Circulation' and is approved by the leading heart health charity, HEART UK.
Commenting on the expanded distribution, Dr Stephen Franklin, CEO of Provexis,
said:
'We are delighted to have received this substantial increased commitment from
the third major retailer prior to the date of its planned launch. Our focused
media campaign to consumers is scheduled to commence on 21 January 2006 and our
sales support activities have been in effect since 10 January'.
For further information please contact:
Provexis plc
Dr Stephen Franklin 020 8392 6631
Bell Pottinger Corporate & Financial
Ann-Marie Wilkinson/Emma Kent 020 7861 3232
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.